8-K
Current Report
Lakewood-Amedex Biotherapeutics Inc. Filed Acc 0001213900-26-069512
Shareholder rights changed · Bylaws or fiscal year change
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading ea0294845-8k_lakewood.htm…